Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 93 for “"Familial hypercholesterolemia"”.
-
Restoring cholesterol homeostasis in familial hypercholesterolemia cell line model
Familial hypercholesterolemia (FH) is an autosomal dominant disorder that results in elevated levels of low-density lipoprotein cholesterol (LDL-C). This increase in serum cholesterol level has been shown to result in premature coronary artery disease (CAD) with devastating symptoms from a young …
-
Phenotypic characterization and cardiovascular outcomes of patients with familial hypercholesterolemia
Background: Familial hypercholesterolemia (FH) is a common autosomal dominant disorder caused by mutations in the low-density lipoprotein (LDL) receptor, apolipoprotein B-100 gene, or proprotein convertase subtilisin/kexin type 9, resulting in very high blood cholesterol levels and premature …
-
Clinical and molecular genetic characterization of patients with familial hypercholesterolemia
Hintergrund und Ziele: Die Familiäre Hypercholesterinämie (FH) ist eine genetisch bedingte Krankheit mit autosomal-dominantem Vererbungsmodus, welche durch erhöhte Serumspiegel von Low-Density-Lipoprotein-Cholesterin (LDL-C) und ein deutlich erhöhtes Risiko für die Entwicklung einer …
-
Cholesterol lowering in familial hypercholesterolemia: studies in man and rabbit
Promotores : A. van ’t Laar, A. Stalenhoef en P. Demacker
-
Variations in Mevalonate Pathway Flux in Human Cells with Familial Hypercholesterolemia
… vitamin K2 biosynthetic enzyme. Individuals with familial hypercholesterolemia (FH) suffer from cholesterol excess due to the inability of cells to take up cholesterol from the environment, leading to a cholesterol depleted cellular state and an increase in cholesterol production. OBJECTIVE: In …
-
Significance of lipoprotein(a) in familial hypercholesterolemia patients: comprehensive literature review /
Lipoprotein(a) and Familial Hypercholesterolemia represent a small group of dyslipidaemias commonly found in patients. Both seem to influence premature atherosclerotic cardiovascular diseases in different ways. Within recent years more and more interest was gained in the exact role of …
-
Genetic Testing Preferences and Intentions in Patients with Clinically Diagnosed Familial Hypercholesterolemia
Purpose Familial Hypercholesterolemia (FH) is a common (1/250) Mendelian disorders that results in elevated LDL cholesterol levels from birth, and if left untreated can result in premature heart disease. Only up to 10% of affected individuals are clinically identified. This is problematic as early …
-
Improving diagnosis and care of familial hypercholesterolemia : from genetic testing to outcomes
Familial hypercholesterolemia (FH) is a genetic disorder characterized by significantly elevated low-density lipoprotein cholesterol (LDL-C) from birth and increased risk of premature atherosclerotic cardiovascular disease (ASCVD). FH is typically caused by pathogenic variants in LDLR, APOB, and …
-
Multiplex Gene Editing in Hepatocytes as a Therapeutic Approach for Familial Hypercholesterolemia
Familial hypercholesterolemia (FH) is a genetic disorder associated with elevated levels of low-density lipoprotein cholesterol (LDL-C) that increases the risk of atherosclerotic cardiovascular disease. FH affects 1 in 250 people.1 Most FH cases are caused by loss-of-function mutations in the …
-
The effects of familial hypercholesterolemia on Achilles tendon biomechanics : a cross-sectional study
Familial hypercholesterolemia (FH), a common genetic metabolic disorder characterized by high cholesterol levels, is involved in the development of atherosclerosis and other preventable diseases. FH can also cause tendinous abnormalities, such as thickening and xanthoma (tendon lipid accumulation) …
-
CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing
付記する学位プログラム名: 京都大学卓越大学院プログラム「メディカルイノベーション大学院プログラム」
-
Population-Wide Genomic Screening: Clinical Outcomes, Economic Value, and Ethics Considerations in Familial Hypercholesterolemia
… economics, and ethics through the use case of familial hypercholesterolemia (FH) and bundled genomic screening. In Chapter 1, we performed a longitudinal statistical analysis estimating the effect of disclosure of pathogenic genetic variants for FH on individuals’ low-density lipoprotein (LDL) …
-
Monogenic hypercholesterolemia in South Africans : familial hypercholesterolemia in Indians and familial defective apolipoprotein B-100
LDL-receptor mutations and familial defective apolipoprotein B-100 (codon 3500) (FOB), the known causes of monogenic hypercholesterolemia (MH), have similar clinical features. The nature of the mutations responsible for MH in South Africans of Indian origin was previously unknown. Similarly, the …
-
Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia
Familial hypercholesterolemia (FH) is an autosomal dominant disorder in which the primary defect is a mutation in the LDL receptor. Heterozygous FH is among the most common inborn errors of metabolism and remains as the best example of an inherited defect causing premature coronary artery disease …
-
Gene Editing Combined With APAP Diet-Mediated Selection in a Ldlr-/- Mouse Model of Familial Hypercholesterolemia
… has garnered significant interest in treating familial hypercholesterolemia (FH), an autosomal co-dominant disorder characterized by elevated low-density lipoprotein cholesterol (LDL-C) levels. However, achieving a therapeutic threshold level of engraftment of gene-modified cells is a …
-
Preliminary validation of a novel genetic knowledge scale for familial hypercholesterolemia: evaluation of face validity and core concepts
… to inherited cardiac conditions, including familial hypercholesterolemia (FH). FH is a common genetic condition that can cause premature atherosclerotic cardiovascular disease (ASCVD) if left untreated. The primary aim of this study was to initiate the validation of an 8-item knowledge scale …
-
Ex Vivo Multiplex Knockdown of ANGPTL3 and Cypor in Hepatocytes as a Novel Cell Therapy for Familial Hypercholesterolemia
… to liver transplantation for treating IMDs. Familial hypercholesterolemia (FH) is and IMD characterized by elevated LDL-C levels resulting in premature cardiovascular disease. CRISPR-Cas9-mediated gene editing to disrupt the gene encoding angiopoietin-like 3 (ANGPTL3) in the liver represents …
Page 1 of 5